HealthStream, Inc. (HSTM) Stock Price & Analysis
HealthStream, Inc. (HSTM) closed at USD 34.59 on Thursday, October 22, 2026, up 3.22% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 34.59; the Oct 22, 2026 session ranged USD 33.74–34.67 on volume of 189,536 shares. Market capitalization is —, with a 52-week range of USD 19.5–34.67 (NMS). Source: Nexqual, retrieved October 23, 2026 at 09:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/HSTM.md
Key facts (HSTM)
- Last four reported quarters (through Jun 30, 2026): revenue $321M, net income $21.2M (6.6% margin), free cash flow $69.8M (SEC filings).
- Valuation: P/E 49.9x (avg 47.0x at the last 3 fiscal year-ends).
- 1 of 80 tracked superinvestors hold HSTM (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Total return with dividends: 1Y +31.3% vs S&P 500 +14.9%; 5Y +24.3% vs S&P 500 +80.3%.
- Next earnings: 2026-11-02, EPS estimate USD 0.15, revenue estimate $82.2M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (HSTM)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $257M | $267M | $279M | $292M | $304M | $321M |
| Operating income | $8.1M | $12.4M | $16.0M | $21.3M | $20.2M | $25.8M |
| Net income | $5.8M | $12.1M | $15.2M | $20.0M | $18.3M | $21.2M |
| EPS (diluted) | $0.18 | $0.39 | $0.50 | $0.66 | $0.61 | — |
| Free cash flow | $39.0M | $49.4M | $61.8M | $56.3M | $59.6M | $69.8M |
| Operating margin | 3.1% | 4.7% | 5.7% | 7.3% | 6.7% | 8.0% |
| Net margin | 2.3% | 4.5% | 5.5% | 6.9% | 6.0% | 6.6% |
| Revenue growth | +4.9% | +3.9% | +4.6% | +4.5% | +4.3% | — |
| Cash + short-term investments | $51.9M | $53.9M | $71.1M | $97.2M | $57.0M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (HSTM)
P/E 49.9x · P/S 3.3x · P/FCF 15.2x · P/B 3.0x · FCF yield 6.60% · Earnings yield 2.00% · Dividend yield (paid, TTM) 0.37% · Buyback yield (TTM) 2.00%
P/E at fiscal year-ends: Dec 2025 37.9x, Dec 2024 48.5x, Dec 2023 54.5x.
Superinvestors (SEC 13F-HR, Q2 2026) (HSTM)
1 of 80 tracked investors hold HSTM. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.03% | $16.1M | Added +39.0% |
Analysts (HSTM)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-13 | Freedom Capital Markets | Initiated | Hold | $36 |
| 2026-07-21 | Canaccord Genuity | Target raised | Hold | $24 → $27 |
Total return (dividends reinvested) (HSTM)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +31.3% | +24.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +31.4% | +4.4% |
| Volatility (annualized) | 32.1% | 27.7% |
| Max drawdown | -24.9% (Oct 2025→Feb 2026) | -41.4% (Apr 2025→Apr 2026) |
HSTM analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.14 | $0.19 | -23.7% | $82.2M | 2 |
| Next quarter (ends Dec 2026) | $0.15 | $0.20 | -25.0% | $82.9M | 2 |
| Current fiscal year (ends Dec 2026) | $0.73 | $0.79 | -7.0% | $329.5M | 1 |
| Next fiscal year (ends Dec 2027) | $0.89 | $0.86 | +2.3% | $344.6M | 2 |
Key Statistics (as of October 23, 2026 at 09:27 UTC)
| Price | USD 34.59 |
|---|---|
| Change | ▲ 3.22% (up) |
| Previous Close | USD 34.59 |
| Open | USD 34.59 |
| Day Range | USD 33.74 – 34.67 |
| 52-Week Range | USD 19.5 – 34.67 |
| Volume | 189,536 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (HSTM)
Nexqual's technical model rates HSTM "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of October 23, 2026 at 09:27 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 76.85 (overbought) |
| vs SMA50 | Above (USD 30.26) |
| MACD | 1.2 (positive) |
Earnings (HSTM)
| Next Earnings Date | 2026-11-02 |
|---|---|
| EPS Estimate | USD 0.15 |
| Revenue Estimate | $82.16M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.23 vs est 0.18 ▲ beat |
| 2026-03-31 | USD 0.2 vs est 0.17 ▲ beat |
| 2025-12-31 | USD 0.18 vs est 0.18 ▲ beat |
| 2025-09-30 | USD 0.2 vs est 0.18 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financials & Fundamentals (HSTM)
| Total Revenue | $321.12M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +12.50% |
| Gross Margin | +65.08% |
| Operating Margin | +9.94% |
| Profit Margin | +6.60% |
| ROE | +6.00% |
| Debt / Equity | 0.04 |
| Current Ratio | 1.06 |
| Total Cash | $66.73M |
| Total Debt | $13.43M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $69.83M (21.7% of revenue) |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financial Health Score (HSTM)
Nexqual rates HealthStream, Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:27 UTC.
| Growth | Mixed — Revenue +4.3% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 65%, operating 10% (last 12 months) |
| Balance Sheet | Strong — $67M cash vs $13M debt, net cash position |
| Cash Flow | Strong — FCF $70M (last 4 quarters to Jun 2026, SEC), 22% margin |
| Efficiency | Mixed — ROE 6%, ROA 3.2% |
Ownership (HSTM)
| Insider Ownership | +29.52% |
|---|---|
| Institutional Ownership | +76.69% |
| Shares Outstanding | 30.60M |
| Float | 20.94M |
| Short % of Float | +6.09% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TDOC | Teladoc Health, Inc. | USD 6.32 | ▲ 0.32% |
| OMDA | Omada Health, Inc. | USD 18.98 | ▼ 3.46% |
| GDRX | GoodRx Holdings, Inc. | USD 3.62 | ▲ 1.4% |
| PHR | Phreesia, Inc. | USD 12.72 | ▲ 3.75% |
| CERT | Certara, Inc. | USD 10.09 | ▼ 0.88% |
| OMCL | Omnicell, Inc. | USD 37.1 | ▲ 2.09% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt